Hydration Support for People Starting GLP-1 RA Therapy
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Recruiting
N/A
Interventional Study
Obesity & Overweight
Type 2 Diabetes
Type 2 Diabetes (Adult Onset)
Obesity Type 2 Diabetes Mellitus
Dehydration
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- State University of New York at Buffalo · Other
Who this trial is looking for
This trial is looking for adults aged 18-60 who have recently started a GLP-1 RA medication for type 2 diabetes. Participants will help test if increasing hydration can reduce side effects from the medication over 16 weeks.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult aged 18-60
- I have been prescribed a GLP-1 RA medication within the last week
- I can speak and understand English
- I am willing to follow the study guidelines
You may not be able to join if
- I am over 60 years old
- I am not taking a GLP-1 RA medication
- I have been on a GLP-1 RA for more than a week
- I am not fluent in English
- I am pregnant or plan to become pregnant during the study
- I am not willing to follow the study guidelines
- I have a cardiac implant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18-60
* Recently prescribed a GLP-1RA (within one week of prescription)
* Fluent in English
* Willing to complete the study protocol
Exclusion Criteria:
* Children and adults \> 60 years of age
* Those not taking a GLP-1RA
* Those who have been on a GLP-1RA longe…
Contacts
No contact information available.